Ikena Oncology

Ikena Oncology company information, Employees & Contact Information

Explore related pages

Related company profiles:

Ikena merged with ImageneBio in July 2025. Please visit https://inmagenebio.com/ for more information.

Company Details

Employees
22
Founded
-
Address
645 Summer Street,
Phone
1-857-273-8343
Email
in****@****ogy.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Boston, Massachusetts
Looking for a particular Ikena Oncology employee's phone or email?

Ikena Oncology Questions

News

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals - GlobeNewswire

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals GlobeNewswire

Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals - Yahoo Finance

Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals Yahoo Finance

Ikena Oncology Stockholders Approve Merger With Inmagene Biopharmaceuticals - citybiz

Ikena Oncology Stockholders Approve Merger With Inmagene Biopharmaceuticals citybiz

Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors - Stock Titan

Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors Stock Titan

Ikena Oncology and Inmagene Biopharmaceuticals to Merger - citybiz

Ikena Oncology and Inmagene Biopharmaceuticals to Merger citybiz

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement - GlobeNewswire

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement GlobeNewswire

Ikena Oncology Announces Strategic Update - Stock Titan

Ikena Oncology Announces Strategic Update Stock Titan

Roche-Acquired Poseida CEO Takes Helm at Ikena-Inmagene Merger with $75M Funding - Stock Titan

Roche-Acquired Poseida CEO Takes Helm at Ikena-Inmagene Merger with $75M Funding Stock Titan

Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors - citybiz

Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors citybiz

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction - GlobeNewswire

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction GlobeNewswire

Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer - citybiz

Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer citybiz

Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update - GlobeNewswire

Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update GlobeNewswire

Ikena Appoints Michelle Zhang, Ph.D., as Chief Scientific Officer - citybiz

Ikena Appoints Michelle Zhang, Ph.D., as Chief Scientific Officer citybiz

Inmagene Reports Topline Results from Phase 2a Study of - GlobeNewswire

Inmagene Reports Topline Results from Phase 2a Study of GlobeNewswire

Top Ikena Oncology Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant